Sign in or Register
  |  

Creative Biolabs has successfully developed SARS, MERS and other anti-viral antibodies in the past to assist scientific research. Facing the difficult COVID-19, Creative Biolabs actively invests in antibody development to assist researchers to better understand the characteristics of 2019-nCoV and drug development. Currently, Creative Biolabs is proud to offer an extensive line of research antibodies to support the study of SARS-CoV-2/COVID-19, several of which were validated using virus-infected cell lysates.

Explore the collections of SARS-CoV-2/COVID-19 antibodies >

About Us

Since 2004, Creative Biolabs has been dedicated to providing high-quality services in academic and life science worldwide. In the past decade, we have become a leader in discovering and manufacturing recombinant antibodies.

In Creative Biolabs, we utilize advanced antibody research tools, professional technical support, and rapid global delivery to ensure quality for scientific research workers and customers in industry. We believe that to build up a custom-service-centered business model is crucial for optimizing the drug development process, leveraging accessible resources, and gathering a team from various backgrounds to conduct drug discovery projects in the future.

As a preferred supplier for global customers, we are confident to provide you with first-class services covering a full range of applications. If you have any need for antibodies, please contact us.